BioSpace News Archive

LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its third quarter 2020 results on Thursday, October 29, 2020 at 12 p.m. London time (8 a.m. Eastern Daylight Time).

OmniVision Technologies, Inc., a leading developer of advanced digital imaging solutions, today announced the OH0120 and OH0130 ASIC-based boards—the newest members of its award-winning OVMed® medical image signal processor (ISP) family, designed to pair with its high performance medical image sensors for quick integration into single-use and reusable endoscopes as well as catheters.

Therapeutics Solutions International, Inc., (OTC Markets: TSOI), reported today positive preclinical data demonstrating superior neuro-regenerative activity to other cell therapies such as mesenchymal stem cells.

Paragonix Technologies announced that its Paragonix SherpaPak™ Cardiac Transport System (CTS) for donor heart preservation and transport is now being used by Stanford Health Care, the first heart transplant center on the West Coast of the United States to implement the system as standard of care for its heart transplant program.

From the Science of Beer to learning about the benefits of GMOs; Saskatchewan is celebrating science with exciting online events and activities that showcase the province’s bioscience sector.

xCures, a clinical study platform provider, announces the US Food and Drug Administration (FDA) granted their IND for an intermediate Expanded Access Program (EAP) for the ERK inhibitor ulixertinib (BVD-523).

CHOP and 38 other health systems in 45 states and Washington, DC have committed to addressing racism and the public health disparities caused by racism

Carbios, a company pioneering new bio-industrial solutions to reinvent the lifecycle of plastic and textile polymers, announced the regrouping of its teams on a single site belonging to Michelin.

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or “the Company”) today announced the launch of a new specialty generic, deferiprone, an iron chelator indicated for the treatment of patients with transfusional iron overload due to thalassemia syndromes when current chelation therapy is inadequate.

Crystal IS, an Asahi Kasei company, and Boston University’s National Emerging Infectious Diseases Laboratories (NEIDL) have performed research demonstrating the efficacy of Crystal IS’ Klaran UVC LEDs to inactivate SARS-CoV-2. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200928005673/en/ Klaran UVC LED (Photo: Business Wire) Crystal IS initia